Provided by Tiger Trade Technology Pte. Ltd.

Park Hotels & Resorts Inc.

15.06
+0.18001.21%
Post-market: 15.060.00000.00%19:30 EDT
Volume:2.53M
Turnover:38.18M
Market Cap:3.03B
PE:-18.22
High:15.22
Open:15.05
Low:14.91
Close:14.88
52wk High:16.20
52wk Low:9.84
Shares:201.40M
Float Shares:195.63M
Volume Ratio:0.92
T/O Rate:1.29%
Dividend:1
Dividend Rate:6.64%
EPS(TTM):-0.8265
EPS(LYR):-1.4300
ROE:-4.86%
ROA:2.75%
PB:0.98
PE(LYR):-10.53

Loading ...

Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial

GlobeNewswire
·
Sep 16

Truist Financial Sticks to Its Hold Rating for Park Hotels & Resorts (PK)

TIPRANKS
·
Sep 15

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study

GlobeNewswire
·
Sep 15

Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial

GlobeNewswire
·
Sep 15

Park Hotels & Resorts Schedules Third-Quarter Earnings Call

Reuters
·
Sep 11

Park Hotels’ CIO Thomas Morey Departs

Reuters
·
Sep 11

Park Hotels Grants CEO Baltimore 331,564-Share Retention Award

Reuters
·
Sep 11

Truist Securities Adjusts Price Target on Park Hotels & Resorts to $17 From $13, Keeps Hold Rating

MT Newswires Live
·
Sep 10

Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium

GlobeNewswire
·
Sep 10

First Infant Data from Ascendis Trial of Once-Weekly TransCon CNP (Navepegritide) Presented at ESPE 2026

GlobeNewswire
·
Sep 10

Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027

GlobeNewswire
·
Sep 09

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

GlobeNewswire
·
Sep 09

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Sep 01

Park Hotels & Resorts Price Target Raised to $18.00/Share from $14.00 by BMO Capital

Dow Jones
·
Sep 01

U.S. Stocks on the MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics

Reuters
·
Sep 01

Park Hotels & Resorts Inc : Bmo Raises to Outperform from Market Perform; Raises Target Price to $18 from $14

THOMSON REUTERS
·
Sep 01

BMO Capital Upgrades Park Hotels & Resorts to Outperform From Market Perform, Adjusts PT to $18 From $14

MT Newswires Live
·
Sep 01

Is Park Hotels & Resorts (PK) A Bargain As Its Share Price Run Raises Valuation Questions?

Simply Wall St.
·
Aug 30

Park Hotels & Resorts is Maintained at Equal-Weight by Barclays

Dow Jones
·
Aug 27

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

GlobeNewswire
·
Aug 25